THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 87 filers reported holding THERAPEUTICSMD INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,734,000 | -55.4% | 33,510 | -58.2% | 0.00% | – |
| Q4 2021 | $28,524,000 | -42.4% | 80,237 | +20.1% | 0.00% | – |
| Q3 2021 | $49,531,000 | +216.8% | 66,807 | +408.5% | 0.00% | – |
| Q2 2021 | $15,634,000 | -79.4% | 13,138 | -76.8% | 0.00% | – |
| Q1 2021 | $75,906,000 | -68.1% | 56,646 | -71.2% | 0.00% | – |
| Q4 2020 | $237,894,000 | +146.0% | 196,607 | +221.2% | 0.00% | – |
| Q3 2020 | $96,717,000 | +295.9% | 61,213 | +213.2% | 0.00% | – |
| Q2 2020 | $24,430,000 | -67.5% | 19,544 | -72.4% | 0.00% | – |
| Q1 2020 | $75,175,000 | +9.9% | 70,920 | +150.8% | 0.00% | – |
| Q4 2019 | $68,430,000 | -42.3% | 28,277 | -13.5% | 0.00% | – |
| Q3 2019 | $118,683,000 | +98.9% | 32,695 | +42.5% | 0.00% | – |
| Q2 2019 | $59,662,000 | -69.9% | 22,947 | -43.6% | 0.00% | – |
| Q1 2019 | $198,078,000 | +2284.8% | 40,673 | +1765.7% | 0.00% | – |
| Q4 2018 | $8,306,000 | -83.3% | 2,180 | -71.3% | 0.00% | – |
| Q3 2018 | $49,876,000 | +9.7% | 7,603 | +4.4% | 0.00% | – |
| Q2 2018 | $45,446,000 | -73.1% | 7,283 | -79.0% | 0.00% | – |
| Q1 2018 | $168,965,000 | -20.2% | 34,695 | -1.0% | 0.00% | – |
| Q4 2017 | $211,768,000 | +139.0% | 35,061 | +109.3% | 0.00% | – |
| Q3 2017 | $88,597,000 | -6.0% | 16,748 | -6.3% | 0.00% | – |
| Q2 2017 | $94,207,000 | +531.2% | 17,876 | +762.3% | 0.00% | – |
| Q1 2017 | $14,926,000 | -90.8% | 2,073 | -91.3% | 0.00% | -100.0% |
| Q4 2016 | $162,235,000 | +109.2% | 23,795 | +109.0% | 0.00% | – |
| Q3 2016 | $77,532,000 | +57.0% | 11,385 | +95.9% | 0.00% | – |
| Q2 2016 | $49,394,000 | -80.5% | 5,811 | -76.2% | 0.00% | -100.0% |
| Q4 2015 | $252,966,000 | +62.1% | 24,394 | -8.4% | 0.00% | – |
| Q3 2015 | $156,099,000 | +87.8% | 26,638 | +151.9% | 0.00% | – |
| Q2 2015 | $83,112,000 | +394.7% | 10,574 | +280.8% | 0.00% | – |
| Q1 2015 | $16,801,000 | -48.5% | 2,777 | -60.5% | 0.00% | – |
| Q3 2014 | $32,652,000 | +5578.6% | 7,037 | +5313.1% | 0.00% | – |
| Q2 2014 | $575,000 | -90.5% | 130 | -90.9% | 0.00% | – |
| Q1 2014 | $6,031,000 | -51.7% | 1,436 | -40.0% | 0.00% | – |
| Q4 2013 | $12,478,000 | -83.0% | 2,395 | -90.5% | 0.00% | – |
| Q3 2013 | $73,511,000 | -22.3% | 25,089 | -19.6% | 0.00% | – |
| Q2 2013 | $94,594,000 | – | 31,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,460,225 | $24,914,000 | 4.95% |
| Newtyn Management, LLC | 1,800,000 | $12,960,000 | 1.95% |
| 1492 Capital Management LLC | 222,485 | $1,602,000 | 1.25% |
| SANDERS MORRIS HARRIS LLC | 967,200 | $6,964,000 | 1.18% |
| MORGENS WATERFALL VINTIADIS & CO INC | 180,000 | $1,296,000 | 1.15% |
| SPHERA FUNDS MANAGEMENT LTD. | 580,000 | $4,176,000 | 0.82% |
| Rock Springs Capital Management LP | 1,600,000 | $11,520,000 | 0.66% |
| STONERIDGE INVESTMENT PARTNERS LLC | 467,425 | $3,365,000 | 0.45% |
| Capital Impact Advisors, LLC | 157,411 | $1,133,000 | 0.45% |
| GILDER GAGNON HOWE & CO LLC | 3,059,690 | $22,030,000 | 0.37% |